LifeStance Health Group, Inc. (LFST)

NASDAQ: LFST · USD

$13.4

+0.26 (+2.0%)· Recorded snapshot

Market cap	5.1B
Revenue (ttm)	1.6B
Net income (ttm)	50.6M
EPS (ttm)	$0.13
Shares out	382.2M
P/E (trailing)	103.7x
P/E (forward)	72.3x
Volume	3,551,262
Beta	1.24

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.6B
Net income (ttm): 50.6M
EPS (ttm): $0.13
P/E (trailing): 103.7x
P/E (forward): 72.3x
Market cap: 5.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ホールド

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E72.3

P25 n/aP50 n/aP75 n/a

Trailing P/E103.7

P25 n/aP50 n/aP75 n/a

ROE3.4

P25 n/aP50 n/aP75 n/a

ROIC3.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LFST indicators

Market & fundamental data

Available fields

248

Groups with data

Currency

USD

Showing 248 of 248 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001845257
Company name	LifeStance Health Group, Inc.
Country	United States
Country code	US
CUSIP number	53228F101
Earnings date	2026-11-05
Earnings time	bmo
Employees	8,542
Employees change	834
Employees growth	10.82%
Enterprise value	$5.4B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
In index	RUSSELL2000
Industry	Medical Care Facilities
IPO date	2021-06-10
Is primary listing	Yes
Is SPAC	No
ISIN number	US53228F1012
Last 10-K release date	2026-02-25
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$5.1B
Market cap category	Mid-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$13.37
Price currency	USD
Sector	Healthcare
SIC code	8000
Stock price date	2026-10-28
Symbol	LFST
U.S. state	Arizona
Website	https://lifestance.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	48.1x
Earnings yield	0.96%
EV/Earnings	106.64x
EV/EBIT	67.07x
EV/EBITDA	39.97x
EV/FCF	31.03x
EV/Sales	3.4x
FCF / EV yield	3.22%
FCF yield	3.38%
Forward EV/Sales	2.96x
Forward P/E	72.3x
Forward P/S	2.83x
Graham number	3.34798
Graham upside	-75.14%
Industry forward P/E	14.95x
Industry P/E	18.37x
P/(FCF - SBC) ratio	49.52x
P/(OCF - SBC) ratio	34.8x
P/B ratio	3.39x
P/E ratio	103.73x
P/FCF ratio	29.6x
P/OCF ratio	23.63x
P/S ratio	3.25x
Price/EBITDA ratio	38.13x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	5.08%
EBITDA margin	8.52%
Effective tax rate	24.47%
FCF margin	10.97%
Gross margin	33.56%
Operating margin	5.08%
Pretax margin	4.23%
Profit margin	3.19%
Profit per employee	$5,924
Profitable quarters	4
Profitable years	1
Revenue per employee	$185,534
ROA	2.32%
ROA (5Y)	-4.02%
ROCE	4.22%
ROE	3.43%
ROE (5Y)	-10.78%
ROIC	3.49%
ROIC (5Y)	-7.64%
SBC / revenue	4.41%
Tax / revenue	1.03%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	63.14%
EPS growth quarters	1
EPS growth years	4
FCF growth	44.84%
FCF growth (Q)	55.22%
FCF growth (QoQ)	293.51%
Gross profit growth	24.24%
Gross profit growth (Q)	41.14%
Gross profit growth 3Y	26.05%
Gross profit growth 5Y	22.75%
Net income growth (QoQ)	65.78%
Net income growth quarters	11
Net income growth years	4
OCF growth	48.88%
OCF growth (Q)	55.15%
OCF growth (QoQ)	201.77%
OCF growth 3Y	86.99%
OCF growth 5Y	92.04%
Operating income growth	5,867.88%
Revenue growth	20.38%
Revenue growth (Q)	26.08%
Revenue growth (QoQ)	7.9%
Revenue growth 3Y	18.22%
Revenue growth 5Y	24.79%
Revenue growth quarters	18
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-44M
Depreciation and amortization	$54.6M
EBIT	$80.4M
EBITDA	$135M
EPS	$0.13
FCF per share	$0.46
Financing cash flow	$-127.9M
Free cash flow	$173.9M
Free cash flow minus SBC	$104M
Gross profit	$531.9M
Income taxes	$16.4M
Investing cash flow	$-53M
Net borrowing	$-10.9M
Net cash flow	$37M
Net income	$50.6M
Operating cash flow minus SBC	$147.9M
Operating income	$80.4M
Revenue	$1.6B
Stock-based compensation	$70M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.53
Book value per share	$3.87
Debt / EBITDA	2.45
Debt / equity	0.32
Debt / FCF	2.73
Goodwill	$1.3B
Interest coverage	7.95
Long-term assets	$1.8B
Long-term liabilities	$429.6M
Net cash (debt)	$-248.2M
Net cash / market cap	-4.82%
Net debt / EBITDA	1.84
Net debt / equity	0.17
Net debt / FCF	1.43
Piotroski F-Score	7
Property, plant and equipment	$321.7M
Shareholders' equity	$1.5B
Tangible book value	$-213,000
Tangible book value per share	$-0.00
Total assets	$2.2B
Total cash	$225.9M
Total debt	$474.2M
Total liabilities	$704.3M
WACC	10.27%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.73
Current assets	$378M
Current liabilities	$274.8M
Current ratio	1.38
Net working capital	$-61.7M
Quick ratio	1.23
Working capital	$103.2M
Working capital turnover	14.42

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.01%
Dividend yield	0%
Shareholder yield	-3.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$10.05
1D price change	2.02%
1M price change	14.11%
1M total return	14.11%
1W price change	10.56%
1W total return	10.56%
1Y price change	164.38%
1Y return CAGR	164.56%
1Y total return	164.38%
20-day SMA	$12.38
200-day SMA	$9.28
3M price change	24.17%
3M total return	24.17%
3Y price change	139.96%
3Y return CAGR	33.87%
3Y total return	139.96%
50-day SMA	$12.45
50-day SMA vs 200-day SMA	50over200
52-week high	$13.63
52-week high date	2026-09-14
52-week low	$4.77
52-week low date	2025-11-03
5Y price change	18.61%
5Y return CAGR	3.47%
5Y total return	18.61%
6M price change	85.83%
6M total return	85.83%
All-time high	$29.81
All-time high date	2021-07-07
All-time low	$3.74
All-time low date	2025-08-01
Average true range (ATR)	$0.42
Average volume	3M
Beta (1Y)	0.25
Beta (2Y)	0.73
Beta (5Y)	1.24
Change from 52-week high	-1.91%
Change from 52-week low	180.19%
Change from all-time high	-54.68%
Change from all-time low	261.23%
Change from open	1.87%
Day's gap	0.15%
Dollar volume	$47.5M
High price	$13.63
Low price	$13.12
Monthly RSI	69.85
Open price	$13.12
Position in 52-week range	48.04%
Premarket change	-1.53%
Premarket close	$13.10
Premarket price	$12.90
Premarket volume	436
Previous close	$13.10
Price vs 150-day SMA	34.47%
Price vs 20-day SMA	9.14%
Price vs 200-day SMA	45.64%
Price vs 50-day SMA	8.49%
Relative volume	1.19
Return from IPO open	-32.65%
Return from IPO price	-25.17%
RSI	69.11
Sharpe ratio	2.03
Sharpe ratio (3Y)	0.78
Sharpe ratio (5Y)	0.29
Sortino ratio	4.29
Sortino ratio (3Y)	1.41
Sortino ratio (5Y)	0.53
Volume	3.6M
Weekly RSI	69.91
YTD price change	91.9%
YTD total return	91.9%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	267M
Float percentage	69.87%
Shares change (QoQ)	-1.97%
Shares change (YoY)	3.01%
Shares held by insiders	3.15%
Shares held by institutions	64.61%
Shares outstanding	382.2M
Short % of float	5.81%
Short % of shares	4.06%
Short ratio	2.7 days

Deeper analysis on LFST

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LFST report

Is a complete LFST research report available?

No complete published report is available for LifeStance Health Group, Inc. (LFST) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LifeStance Health Group, Inc. (LFST)

Price

Financial snapshot

Fair-value bridge

Latest news · LFST

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LFST indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LFST

Frequently asked questions